(Q70282767)
Statements
Phase II trial of razoxane (ICRF-159) in patients with squamous cell carcinoma of the head and neck previously exposed to systemic chemotherapy (English)
Shah MK
Engstrom PF
Catalano RB
Paul AR
Bellet RE
scientific article published on 01 March 1982